Skip to main content

Table 1 Baseline clinical and biological characteristics of MM patients

From: Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation

Characteristics

all patients

CD56 positive

CD56 negative

p value

n = 370

n = 250

n = 120

n (%)

n (%)

n (%)

Sex

 Male

203 (54.9)

129 (51.6)

74 (61.7)

0.07

 Female

167 (45.1)

121 (48.4)

46 (38.3)

Median age (range) [years]

56 (33–65)

56 (33–65)

57 (33–65)

0.59

MM subtype

 IgG

185 (50.0)

137 (54.8)

48 (40.0)

0.00

 IgA

73 (19.7)

54 (21.6)

19 (15.8)

 IgD

22 (5.9)

5 (2.0)

17 (14.2)

 Light chain only

78 (21.1)

48 (19.2)

30 (25.0)

 Non-secretory

12 (3.2)

6 (2.4)

6 (5.0)

ISS stage

 I

78 (21.1)

46 (18.4)

32 (26.7)

0.11

 II

123 (33.2)

90 (36.0)

33 (27.5)

 III

169 (45.7)

114 (45.6)

55 (45.8)

Hemoglobin

  < 100 g/L

229 (61.9)

160 (64.0)

69 (57.5)

0.23

  ≥ 100 g/L

141 (38.1)

90 (36.0)

51 (42.5)

Serum creatinine

  ≤ 2 mg/dL

309 (83.5)

210 (84.0)

99 (82.5)

0.72

  > 2 mg/dL

61 (16.5)

40 (16.0)

21 (17.5)

Corrected serum calcium

  ≤ 2.75 mmol/L

323 (87.3)

214 (85.6)

109 (90.8)

0.16

  > 2.75 mmol/L

47 (12.7)

36 (14.4)

11 (9.2)

Lactate dehydrogenase

  ≤ 250 U/L

318 (85.9)

219 (87.6)

99 (82.5)

0.19

  > 250 U/L

52 (14.1)

31 (12.4)

21 (17.5)

Cytogenetic abnormalities by FISH

del(17p13)

 abnormality

40 (10.8)

30 (12.0)

10 (8.3)

0.29

 non-abnormality

330 (89.2)

220 (88.0)

110 (91.7)

t(14; 16)

 abnormality

15 (4.1)

2 (0.8)

13 (10.8)

0.00

 non-abnormality

355 (95.9)

248 (99.2)

107 (89.2)

t(4; 14)

 abnormality

69 (18.6)

67 (26.8)

2 (1.7)

0.00

 non-abnormality

301 (81.4)

183 (73.2)

118 (98.3)

Induction regimes

 Bortezomib based

167 (45.1)

114 (45.6)

53 (44.2)

0.90

 IMiD based

30 (8.1)

21 (8.4)

9 (7.5)

 Bortezomib and IMiD based

173 (46.8)

115 (46.0)

58 (48.3)

ASCT

 Yes

194 (52.4)

137 (54.8)

57 (47.5)

0.19

 No

176 (47.6)

113 (45.2)

63 (52.5)

  1. Abbreviations: IMiD Immunomodulatory, ASCT Autologous stem cell transplant